Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory ...

Please provide your email address to receive an email when new articles are posted on . In a prospective study, researchers enrolled 457 asymptomatic participants (mean age 61.4 years; 75% women) from ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pediatric patients with ulcerative colitis who displayed a rapid drop-off of fecal calprotectin ...

I am still haunted by my initiation to Crohn disease. My late brother Andrew, who succumbed to the illness because of a confluence of complications at 29 years-old, first manifested symptoms as a ...

Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...

Although not currently recommended as a formal therapeutic target in ulcerative colitis (UC) management, histologic healing is associated with improved long-term clinical outcomes. In a small ...

Background: The early bacterial colonization of the intestine post partum may affect gut inflammation and risk for disease. Very low birth weight infants (VLBW, < 1500 g) are at risk for ...

Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent ...

SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- ProciseDx Inc. announced today that it has received CE mark for its Fecal Calprotectin (Procise FCP™) point of care tests for use on the ProciseDx™ system.

Background: Calprotectin is a calcium binding protein, abundant in neutrophils and stable in faeces. The aims of this study were to assess faecal calprotectin concentrations (f-calprotectin) in very ...

SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...

A 10-year-old boy presents for evaluation of diarrhea. He was well until 3 weeks ago, when he started to pass loose stools three to four times per day. In the 5 days before presentation, he developed ...